![]() |
||||
|
|
||||
|
|
||||
|
|
Very important Lupron article...everyone should see this from 1999From: andrea (anonymous@obgyn.net)Wed Oct 10 19:22:58 2007
This is a new one, I've never seen this before. http://www.endocenter.org/pdf/gnrhwitharticles.pdf PLEASE PRINT THIS AND READ IT AND DOCTORS WON'T BE ABLE TO ASK YOU TO TAKE THIS DRUG AGAIN! BACK IN 1999: This is just part of what the article says: To date, the FDA reports 6,272 complaints filed for adverse side effects from Lupron - 553 have come within the past 20 months. During the past two years roughly 2 million prescriptions were written for Lupron in the United States, according to IMS Health, a Pennsylvania company that tracks prescription drugs. In a report submitted by TAP Pharmaceuticals to the FDA in April 1998, researchers wrote that they were “concerned” because more than one-third of the women they studied who took Lupron did not “demonstrate either partial reversibility” or “a trend toward return” of bone mass in the six months after they stopped taking the drug. Further, the researchers noted some women lost as much as 7.3 percent of their bone density during treatment - more than twice the amount the drug’s packaging lists in its warnings. Reporting drug woes: To report a suspected adverse side effect from a drug or medical device, call the federal Food and Drug Administration at (888) INFO- FDA. Consumers can also file reports on line at http://www.fda.gov (click on MedWatch Medical Products Reporting). “The patient’s identity is held in strict confidence by the FDA and protected to the fullest extent of the law,” the federal agency says. Contact TAP Pharmaceuticals Medical Services Department at (800) 622-2011, or http://www.lupron.com. Call the National Lupron Victims Network at (609) 858-2131. The Internet address is http://www.voicenet.com/~nlvn.
|
|
Return to ![]()
Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 03:59:42 2009
Women's Insurance Checklist from Auto Insurance Quote
home | medical professionals | women | industry | forums | international